Mirizzi's syndrome: Difference between revisions
Line 19: | Line 19: | ||
==Overview== | ==Overview== | ||
==Epidemiology== | ==Epidemiology== |
Revision as of 19:54, 5 September 2012
| |
ICD-9 | 576.2 |
---|---|
DiseasesDB | 33254 |
Mirizzi's syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mirizzi's syndrome On the Web |
American Roentgen Ray Society Images of Mirizzi's syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology
Pathophysiology
Multiple and large gallstones can reside chronically in the Hartmann's pouch of the gallbladder, causing inflammation, necrosis, scarring and ultimately fistula formation into the adjacent common bile duct (CBD). As a result, the CBD becomes obstructed by either scar or stone, resulting in jaundice. It can be divided into four types. Type I does not involve a fistula at all. Type II- IV involve fistulas of different sizes.
Type II is classified as a fistula of <33%of the CBD width, Type III Mirizzi Syndrome involves a fistula between 33% and 66% of the CBD width, and Type IV involves a fistula of greater than 66% of the CBD width.
Features
Mirizzi syndrome has no consistent or unique clinical features that distinguish it from other more common forms of obstructive jaundice. Symptoms of recurrent cholangitis, jaundice, right upper quadrant pain, and elevated bilirubin and alkaline phosphatase may or may not be present. Acute presentations of the syndrome include pancreatitis or cholecystitis.
Diagnosis
CT scan or ultrasonography usually make the diagnosis. Often, ERCP is used to define the lesion anatomically prior to surgery.
Treatment
The treatment of choice is surgical excision of the gallbladder, and reconstruction of the common hepatic duct and common bile duct.
Eponym
It is named for Pablo Mirizzi.[1][2]
References
- ↑ Template:WhoNamedIt
- ↑ Mirizzi PL: Syndrome del conducto hepatico. J Int de Chir 1948; 8: 731-77
Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4